ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Orlando, FL, USA:

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...

Active, not recruiting
Pancreatic Cancer
Radiation: Stereotactic MRI-guided On-table Adaptive Radiation Therapy
Viewray

Orlando, Florida, United States and 12 other locations

and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...

Enrolling
Advanced Pancreatic Cancer
Drug: Gemcitabine
Drug: Zimberelimab

Phase 1

Arcus Biosciences
Arcus Biosciences

Orange City, Florida, United States and 17 other locations

This study is an open-label, international, multi-center, Phase 1 study in adult patients with solid tumors likely to express CLDN18.2....

Enrolling
Digestive System Neoplasm
Neoplasms
Drug: EO-3021

Phase 1

Elevation Oncology

Orlando, Florida, United States and 19 other locations

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer...

Active, not recruiting
Chemotherapy-induced Thrombocytopenia
Other: Placebo
Biological: Romiplostim

Phase 3

Amgen
Amgen

Orange City, Florida, United States and 116 other locations

A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated d...

Enrolling
Solid Tumor
Cancer of Colon
Drug: HBI-2376

Phase 1

HUYABIO

Orlando, Florida, United States and 11 other locations

A Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation....

Enrolling
Solid Tumor
Pancreatic Adenocarcinoma
Drug: MRTX1133

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Lady Lake, Florida, United States and 15 other locations

as PK and pharmacodynamics of XL309 (previously ISM3091) administered alone or in combination with olaparib in subjects with advanced solid tumors...

Enrolling
Advanced Solid Tumor
Drug: Olaparib
Drug: XL309 (ISM3091)

Phase 1

Exelixis
Exelixis

Orlando, Florida, United States and 11 other locations

This is a Phase 1/2, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with a...

Enrolling
Solid Tumor
Malignant Peripheral Nerve Sheath Tumors
Drug: MRTX1719

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Orlando, Florida, United States and 20 other locations

This study is open to adults with advanced solid tumors whose previous cancer treatment was not successful. People can participate ...

Active, not recruiting
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal Neoplasms
Drug: BI 765049
Drug: ezabenlimab

Phase 1

Boehringer Ingelheim
Boehringer Ingelheim

Orlando, Florida, United States and 13 other locations

The goal of this clinical trial is to evaluate FMC-376 in participants with advanced solid tumors with KRAS G12C mutations. This clinical tr...

Enrolling
Solid Tumor, Adult
Unresectable Solid Tumor
Drug: FMC-376

Phase 1, Phase 2

Frontier Medicines

Lake Mary, Florida, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems